Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Popat

Showing results (21-30 of 82) with videos related to

Pageof 9
Sort By:
Dental Update|November 18, 2017
Authors' responseA E Moore, T Renton, T Taylor, et al.
European Journal of Cancer (Oxford, England : 1990)|June 21, 2011
Under usage of zoledronic acid in non-small cell lung cancer patients with metastatic bone disease--a short communicationR Calderone, K Nimako, A Leary, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 2, 2013
Small-cell lung cancer (SCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upM Früh, D De Ruysscher, S Popat, et al.
Scandinavian Journal of Gastroenterology|June 13, 2002
Mutational analysis of CD28 in coeliac diseaseS Popat, N Hearle, S Bevan, et al.
Lung Cancer (Amsterdam, Netherlands)|January 15, 2013
Transformation to "high grade" neuroendocrine carcinoma as an acquired drug resistance mechanism in EGFR-mutant lung adenocarcinomaS Popat, A Wotherspoon, C M Nutting, et al.
Cancer Letters|March 29, 2000
Prevalence of the APC E1317Q variant in colorectal cancer patientsS Popat, J Stone, G Coleman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 14, 2014
Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upM Reck, S Popat, N Reinmuth, et al.
European Journal of Gastroenterology & Hepatology|December 14, 2001
Germline mutations in TGM2 do not contribute to coeliac disease susceptibility in the Swedish populationS Popat, L Hogberg, S McGuire, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 26, 2025
Updated treatment recommendations for systemic treatment: from the ESMO oncogene-addicted metastatic NSCLC living guidelineL E L Hendriks, F Cortiula, D Martins-Branco, et al.
British Journal of Cancer|January 28, 2010
Treatment options for small cell lung cancer - do we have more choice?M Puglisi, S Dolly, A Faria, et al.
Pageof 9

Showing results (21-30 of 82) with videos related to

Sort By:
Pageof 9
Dental Update|November 18, 2017
Authors' responseA E Moore, T Renton, T Taylor, et al.
European Journal of Cancer (Oxford, England : 1990)|June 21, 2011
Under usage of zoledronic acid in non-small cell lung cancer patients with metastatic bone disease--a short communicationR Calderone, K Nimako, A Leary, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 2, 2013
Small-cell lung cancer (SCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upM Früh, D De Ruysscher, S Popat, et al.
Scandinavian Journal of Gastroenterology|June 13, 2002
Mutational analysis of CD28 in coeliac diseaseS Popat, N Hearle, S Bevan, et al.
Lung Cancer (Amsterdam, Netherlands)|January 15, 2013
Transformation to "high grade" neuroendocrine carcinoma as an acquired drug resistance mechanism in EGFR-mutant lung adenocarcinomaS Popat, A Wotherspoon, C M Nutting, et al.
Cancer Letters|March 29, 2000
Prevalence of the APC E1317Q variant in colorectal cancer patientsS Popat, J Stone, G Coleman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 14, 2014
Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upM Reck, S Popat, N Reinmuth, et al.
European Journal of Gastroenterology & Hepatology|December 14, 2001
Germline mutations in TGM2 do not contribute to coeliac disease susceptibility in the Swedish populationS Popat, L Hogberg, S McGuire, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 26, 2025
Updated treatment recommendations for systemic treatment: from the ESMO oncogene-addicted metastatic NSCLC living guidelineL E L Hendriks, F Cortiula, D Martins-Branco, et al.
British Journal of Cancer|January 28, 2010
Treatment options for small cell lung cancer - do we have more choice?M Puglisi, S Dolly, A Faria, et al.
Pageof 9